Vertex Pharmaceuticals Incorporated (0QZU.L) LSE

462.57

+3.9102(+0.85%)

Updated at December 24 05:37PM

Currency In USD

Valuation

Market Cap103.7B
Enterprise Value100.88B
P/E Ratio32.2
PEG Ratio23.96
Price/Sales Ratio10.13
Price/Book Ratio4.76
Enterprise/Revenue9.87
Enterprise/EBITDA25.12

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.31
Operating Margin0.34

Management Effectiveness

Return On Assets0.15
Return On Equity0.2

Income Statement

Revenue11.02B
Revenue/Share45.87
Gross Profit9.49B
EBITDA486.3M
Net Income-535.6M
Diluted EPS-2.08

Balance Sheet

Total Cash6.29B
Total Cash/Share24.6
Total Debt1.83B
Total Debt/Equity0.07
Current Ratio2.36
Book Value Per Share67.76

Price History

52-Week Change14.13
52-Week High463.96
52-Week Low290.87
Moving Average 50 Days424.38
Moving Average 200 Days373.25

Statistics

Average Volume2,907
Shares Outstanding256.62M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A